3 active warrant series covering 119,510,545 shares (~40.9% potential dilution); nearest expiry 2028-11-02.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.05 | Nov 2, 2028 764d | 48.6M | ITM | 16.6% | C$2.4M | Auto |
| warrant | $0.05 | Jun 18, 2029 992d | 29.0M | ITM | 9.9% | C$1.4M | Auto |
| warrant | $0.05 | Jul 7, 2030 1376d | 42.0M | ITM | 14.4% | C$2.1M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
2 option grants covering 708,000 shares (~0.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.06 | Feb 28, 2027 151d | 168K | OTM | 0.1% | C$10K | Auto |
| option | $0.05 | Sep 15, 2029 1081d | 540K | ITM | 0.2% | C$27K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
292,453,997 shares outstanding, plus 119,510,545 from warrants and 708,000 from options — a fully diluted 412,672,542 shares, or ~41.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
3 active warrant series covering 119,510,545 shares (~40.9% potential dilution); nearest expiry 2028-11-02.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.05 | Nov 2, 2028 764d | 48.6M | ITM | 16.6% | C$2.4M | Auto |
| warrant | $0.05 | Jun 18, 2029 992d | 29.0M | ITM | 9.9% | C$1.4M | Auto |
| warrant | $0.05 | Jul 7, 2030 1376d | 42.0M | ITM | 14.4% | C$2.1M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
2 option grants covering 708,000 shares (~0.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.06 | Feb 28, 2027 151d | 168K | OTM | 0.1% | C$10K | Auto |
| option | $0.05 | Sep 15, 2029 1081d | 540K | ITM | 0.2% | C$27K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
292,453,997 shares outstanding, plus 119,510,545 from warrants and 708,000 from options — a fully diluted 412,672,542 shares, or ~41.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
